Objective: Wegener's granulomatosis (WG) is a necrotizing vasculitis that mainly affects the respiratory tract and kidneys, but can also affect other systems such as the eye, joints, skin, muscles, nerves, and gastrointestinal tract. Cardiac involvement is traditionally believed to be rare. We report a patient with silent myocardial infarction (MI) and review previously reported cases showing this association. Methods: A Medline database search of cases published between January 1978 and July 2008 both in English and Spanish, reporting silent MI complicating WG, was conducted. Results: We describe a typical patient with WG who had both respiratory and renal involvement and died unexpectedly following a silent MI after a period of clinical improvement induced by treatment with prednisone and cyclophosphamide. We report necropsy findings and the association with 5 additional cases of WG with silent MI reported in the literature. Conclusions: Clinicians should be aware of potential cardiac involvement due to WG. Careful evaluation of each patient, with or without cardiac symptoms, using ECG, echocardiogram, and myocardial enzymes is prudent.
Introduction
Wegener's granulomatosis (WG) is a necrotizing granulomatous vasculitis that mainly affects the upper and lower respiratory tract and kidneys [1] . Since the first description of the disease in 1931 [2, 3] , numerous case reports and reviews have documented other end-organ involvement, underscoring the disseminated nature of this disease.
Cardiac involvement in WG, including subclinical forms, is not as rare as previously considered, ranging between 6 and 44% of cases [4] . The high range is associated with more advanced disease and a higher rate of postmortem examinations [5] . Interestingly, Morelli et al. [6] recently reported results of 9 patients with WG without known cardiac involvement who all proved to have abnormalities during transthoracic echocardiographic examination.
In this report, we describe a patient with both respiratory and renal involvement who died unexpectedly following a silent myocardial infarction (MI) after a period of clinical improvement induced by treatment with cyclophosphamide and prednisone. In this context, we review the previous literature dealing with the association between necrotizing glomerulonephritis (WG) and silent cardiac implications, with special emphasis on the relationship between both processes.
Methods
A literature review from January 1966 to July 2008 was performed using Medline (PubMed). Cases with coexisting WG and silent MI were searched. Only 5 cases published in either English or Spanish were found for review.
Case Report
We report the case of a 22-year-old male who was admitted to the Nephrology Department of La Raza Medical Center, Instituto Mexicano del Seguro Social, Mexico City, for the first time in September 2007 with an 8-month history of nasal congestion and 2-month history of painful lower extremities, dizziness, fever, fatigue, arthralgia, coughing, and dark urine. The patient's history was otherwise negative except for arterial hypertension for 1 year before admission, for which captopril was prescribed but sporadically taken. In addition, during the previous week the patient reported redness of his left eye, ear pain, and nasal discharge of 'bloody' mucus. He had noticed increasing nocturia from 1 to at least 3 or 4 episodes each night. Despite a 1-week course of antibiotic treatment for sinusitis, there was no respiratory tract improvement. The patient reported no previous significant medical history except for longstanding sensitivity to sunlight. There was no relevant family history. Although the patient was afebrile, clinical examination demonstrated the patient to be in poor health. He was in severe pain due to swollen joints and multiple vasculitic lesions over the feet and face. His right foot was cold with an absent dorsalis pedis pulse. There was no lymphadenopathy, hepatomegaly or splenomegaly. His pulse rate was 115/ min, blood pressure (BP) 150/90 mm Hg and there were normal sounds with no murmurs. Auscultation of the lung fields revealed only normal breath sounds. Laboratory analysis demonstrated hemoglobin of 10 g/dl and white blood count of 14 ! 10 9 /l. Urea was 68 mg/dl and creatinine 2.4 mg/dl. Urine testing revealed blood and protein with a creatinine clearance of 44 ml/min. Erythrocyte sedimentation rate was 110 mm/h and C-reactive protein was 140 mg/dl. Anti-neutrophil cytoplasmic antibodies were positive at a titer of 1: 320 with a cytoplasmic staining pattern by ELISA on purified antigen. Anti-nuclear antibody, rheumatoid factor, and anti-glomerular basement membrane were negative. Electrocardiogram (ECG) was normal and echocardiogram revealed no abnormality other than tachycardia. A biopsy of the patient's nasal tissue was performed, demonstrating granulomatous tissue with necrosis and inflammation with eosinophils, lymphocytes, and some giant cells; C3, C4, and IgG were negative by immunochemistry staining.
A diagnosis of WG was made and immunosuppressive treatment was begun. The patient was given three 1-gram i.v. pulses of methylprednisolone on alternate days followed by 60 mg of oral predniso-lone and 150 mg of cyclophosphamide daily. He also underwent a course of plasma exchange totaling 26 liters and, in addition, was transfused with 2 U of packed cells. His clinical status improved within 72 h. The vasculitic skin lesions on the feet and face and dorsalis pedis pulses began to resolve and no new lesions appeared. Erythrocyte sedimentation rate decreased to 40 mm/h after 2 days and continued to decrease. After 1 week, C-reactive protein was 12 mg/l. The patient remained mildly hypertensive (BP 130/90 mm Hg) and, in view of the persistent tachycardia, a cardiology consultation was sought. This confirmed the presence of a sinus tachycardia with an otherwise normal ECG and no evidence of cardiac disease. Glutamic pyruvic transaminase, glutamic oxaloacetic transaminase, and creatine kinase (CK) were normal.
Three weeks after initiation of immunosuppressive therapy, the patient's condition suddenly deteriorated. His pulse rate increased to 140/min and was associated with hypotension (BP 90/60 mm Hg) and a gallop rhythm. A repeat ECG showed acute anterior and acute inferior wall Q-wave infarctions, with anterior infarct, ST elevation in leads II and aVL and the precordial leads, accompanied by reciprocal ST depressions in leads III and aVF ( fig. 1 b; admission ECG shown in fig. 1 a) . Echocardiography showed septal akinesia and diffuse hypocontractility without dilatation of the left ventricle. Silent acute anterior and inferior wall MI was diagnosed. CK concentration was 340 U/l with CK isoenzyme MB 174 U/l. At no time did the patient complain of chest pain. Despite maximal inotropic support, the patient's clinical evolution demonstrated worsening cardiogenic shock. He died 3 days later. Permission for postmortem examination was given.
Necropsy Findings
Necropsy confirmed a severe and disseminated necrotizing granulomatosis affecting the lungs, kidneys, spleen, skin, and heart. A florid systemic vasculitic component was present in these organs, in the aorta, and in its main distributing branches. Pulmonary arterioles showed a florid transmural and fibrinoid vasculitis with a heavy infiltrate of polymorphonuclear leucocytes, vessel wall necrosis, and giant cells. Kidney cortices were pale, and microscopy showed extensive necrotizing glomerulitis with fibrin aggregates and exudates of polymorphonuclear leucocytes. This heavy inflammation was centered on the glomeruli and radiated to the surrounding interstitium. Capsular epithelial crescents were present ( fig. 2 ) . Intrarenal vessels of all sizes were acutely inflamed and fibrinoid in appearance, and there was papillary necrosis. 
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Purpura noted on clinical examination correlated with an acute vasculitic process in the dermis and subcutaneous fat. Splenic vessels were affected, resulting in multiple recent infarcts in the enlarged spleen (380 g). The heart weighed 540 g, and there was fibrinous pericarditis. Microscopy showed the endocardia of both atria were thickened and inflamed with foci of fibrinoid necrosis and a palisading granulomatous reaction of inflammatory cells. Similarly, foci were present in the epicardium, base of the mitral valve, and myocardium of the proximal interventricular septum where giant cells were present. Coronary arteries demonstrated focally inflamed intima with acute anteroseptal MI with occlusive vasculitic thrombosis of the left coronary artery. Microscopy showed diffuse vasculitis and inflammatory and necrotizing fibrinoid granulomata ( fig. 3 ) .
Aortic intima and iliac arteries were affected by this granulomatous vasculitis, and the right posterior tibial artery and vein were occluded, secondary to vasculitic thrombosis.
Discussion
WG, a systemic inflammatory disorder of unknown cause, is a necrotizing and granulomatous vasculitis that usually affects the upper and lower respiratory tract and kidneys [7, 8] . Cardiac involvement is generally thought to be rare, although ECG abnormalities, coronary artery vasculitis, cardiac arrhythmias, pericarditis, myocarditis, valvulitis, and MI have been described [9] [10] [11] . In aggregate, histopathological studies demonstrated 30% incidence of cardiac involvement. The pericardium was the most common site of this involvement occurring in 50% of cases, with the other 50% involving the coronary arteries. Pericardial pathology has demonstrated diffuse, as well as focal, areas of involvement. Pericardial effusions and cardiac tamponade have been reported [4, 7] . The endocardium (including valves), myocardium, and epicardium are also targets of the vasculitic process. The epicardium has shown granulomatous inflammatory foci [4, 7] and the myocardium has shown granulomatous foci, perivascular inflammation and necrotizing arteriolitis. The endocardium and valves were also involved in several cases with inflammation, fibrinoid necrosis, and granulomatous formation of the mitral and, less commonly, tricuspid valves [7, 12] . Although the incidence of the cardiac conduction system in WG patients has not been investigated, it appears that atrial and supraventricular arrhythmias are more common than ventricular arrhythmias [4, 7] .
Coronary vasculitis has been reported in ϳ 50% of autopsy cases of WG in which the heart was examined at autopsy.
Clinical manifestations such as angina pectoris and MI are uncommon [7, 11] . The coronary vessels showed a spectrum of vasculitic stages from acute necrotizing activity to healing stages. Other potential mechanisms of ischemia include coronary artery embolism from contiguous aortic valvulitis [13, 14] and aortitis-related ostial stenosis [14] . The association of WG with MI in living subjects has been described in several series [8, 9, 11, 12, 15] . Notably, in 5 of these cases, as in our case, there were no chest complaints [8, 9, 11, 12, 16] ( table 1 ) despite typical manifestations of WG. Five of the cases were fatal, suggesting that MI in these patients carries a dismal prognosis. The true frequency of these abnormalities, however, is difficult to establish because the proportion of cases subjected to detailed postmortem histological examination is variable.
Literature concerning cardiac involvement and immunosuppressive therapy with cyclophosphamide is limited and controversial; in some cases, immunosuppressive therapy allowed a complete resolution of the cardiac lesion [17, 18] was largely due to the relatively high incidence of MI, particularly in those with advanced age at the time of diagnosis, in males, and in those treated with high doses of cyclophosphamide [9, 11] . This study confirmed the results of previous reports, indicating that patients with WG frequently experience 'silent' MI, which may further contribute to an increase of mortality rates.
Our case is atypical in that cardiac complications occurred several days after treatment initiation at a time when the patient's clinical status showed improvement and the only manifestation was persistent tachycardia in the absence of fever and associated with arterial hypotension. The reason for such an extensive anteroseptal infarct without symptoms is unknown. In fact, the acute event in this patient was not diagnosed until the development of cardiogenic shock, and a different clinical outcome is unlikely had the infarct been diagnosed earlier. Table 1 shows all characteristics of the 6 reported cases in the literature of silent ischemic heart disease in patients with glomerulonephritis due to WG.
Several similarities have been observed in all cases: (1) MI was the first cardiac manifestation. In conclusion, there is convincing evidence that, in contrast to traditional teaching, the heart is frequently affected in necrotizing glomerulonephritis due to WG, presenting a variety of manifestations: either subtle, subclinical or atypically symptomatic. In particular, these manifestations included pericarditis, myocarditis, arrhythmias, and silent coronary events. We report an unusual timing of cardiac manifestation -a case of silent ischemic heart disease with glomerulonephritis due to WG, occurring after initiation of anti-vasculitic treatment. 
